Expanding Global Capability Through Trusted Scientific Collaboration
Our Global Network
Nikao Life Sciences partners with trusted scientific and operational organizations across the United States, Europe, China, and India to support globally coordinated nonclinical programs. These strategic collaborations allow us to deliver region-specific expertise, efficient study placement, and seamless operational execution all under Nikao’s centralized scientific oversight. With this integrated global network, we help clients select the right research environment for the right study, ensuring quality, compliance, and regulatory alignment across borders.
Trusted Access to China-Based CRO & CDMO Capabilities
Trusted Access to China-Based CRO & CDMO Capabilities
To support programs requiring China-based technical execution, Nikao Lifesciences collaborates with BioMed Linkage Tech Co., Limited, a highly reputable provider of CRO and CDMO services. This collaboration expands our ability to help clients leverage China’s broad research infrastructure while ensuring that scientific integrity, data quality, and regulatory expectations remain consistent with global standards
Capabilities Accessible Through This Partnership:
- Pharmacology & efficacy studies
- DMPK / ADME services
- GLP and non-GLP toxicology
- Medical device and combination product testing
- Formulation development & CDMO support
Nikao Lifesciences acts as the scientific and regulatory lead, providing:
- Study design & protocol review
- CRO qualification & suitability assessment
- Communication oversight & progress monitoring
- Data interpretation & report quality review
- Alignment with FDA/EMA/ICH expectations
Value to Clients:
- Access to cost-effective, high-capacity CRO resources
- Regionally specialized technical capabilities
- Reliable timelines supported by local infrastructure
- ted by local infrastructure
- Streamlined communication managed by Nikao
- Scientific consistency across multi-region programs
Global Reach. Local Expertise. Centralized Oversight.
Our partnerships across the US, EU, China, and India allow us to:
CRO & Vendor Selection
We identify, evaluate, and recommend CROs based on capability, compliance, performance history, and regulatory suitability.
Cross-Border Study Placement
Nikao matches the right study to the right region — considering cost, timelines, regulatory relevance, and technical expertise.
Region-Specific Regulatory Insight
We provide guidance tailored to FDA, EMA, NMPA, MHRA, PMDA, and ICH expectations.
Integrated Global Study Oversight
- Standard quality frameworks
- GLP oversight
- Cross-region data harmonization
- Real-time communication
- Scientific integrity checks
Why Our Global Network Matters
- Cost-effective study placement
- Access to diverse technical capabilities
- Faster turnaround times
- Consistent global quality oversight
- Single-point accountability with Nikao
- Fewer communication barriers
- Efficient coordination between regions
Whether your program requires specialized toxicology, advanced PK studies, device testing, or China-based IND-enabling work — our global network supports efficient and compliant execution.
Your Program, Globally Supported
Nikao Life Sciences is committed to providing clients with access to international capability without the complexity of managing multiple vendors or regions independently. We connect global resources — and deliver one unified scientific standard.
Ready to explore global CRO options or leverage China-based capabilities? Our team can guide you through strategy, vendor selection, and execution oversight.
Expanding Nikao’s Global Scientific and Operational Capability
Our Strategic Partner in India
To strengthen our global execution framework, Nikao Life Sciences collaborates with a trusted scientific partner in India, enabling high-quality, cost-efficient nonclinical support across key research areas. This partnership enhances our ability to provide clients with regional expertise, operational flexibility, and access to India’s expanding research infrastructure all under Nikao’s centralized scientific oversight.
Our India-based partner provides access to a wide range of nonclinical capabilities, including:
- Pharmacology and efficacy studies
- General toxicology and specialist toxicology
- Safety pharmacology
- Exploratory and IND-enabling study models
- Bioanalytical and formulation support
- Device and combination-product evaluations
This partnership allows Nikao Lifesciences to place and oversee studies efficiently in India while maintaining full alignment with global scientific and regulatory expectations (FDA, EMA, ICH, MHRA, PMDA).
Nikao’s Oversight Role in India
- Study design is aligned with clinical intent and regulatory strategy
- CRO capability and suitability are assessed and qualified
- Communication is streamlined through Nikao (not the CRO)
- Data quality, GLP integrity, and timelines are monitored real-time
- Final reports are reviewed for scientific rigor and submission readiness
- All work harmonizes with global data packages
Our team acts as your single point of accountability, reducing communication burden and ensuring consistent quality across regions.
Leveraging our strategic partner in India provides:
- Cost-effective study options without compromising scientific integrity
- Access to specialized regional scientific capabilities
- Shorter timelines due to established infrastructure and resource availability
- Strong local coordination supported by regional operational familiarity
- Nikao-led interpretation and regulatory alignment to global standards
This model ensures clients benefit from India’s research strengths, while maintaining the scientific quality and regulatory precision Nikao is known for.
Strategic Global Integration
Our India partnership is part of Nikao Life Sciences’ broader global network across:
- United States
- Europe
- China
- India